January 7, 2013
520-Day Simulated Mission to Mars Reveals Critical Data about Sleep and Activity Needs for Astronauts
Success of Interplanetary Human Spaceflight Hinges on Routine Sleep and Behavioral Activity, Multicenter Study Shows
PHILADELPHIA — In the first study of its kind, a team of researchers led by faculty at the Perelman School of Medicine at the University of Pennsylvania and the Baylor College of Medicine, has analyzed data on the impact of prolonged operational confinement on sleep, performance, and mood in astronauts from a groundbreaking international effort to simulate a 520-day space mission to Mars. The findings, published online-first in the Proceedings of the National Academy of Sciences, revealed alterations of life-sustaining sleep patterns and neurobehavioral consequences for crew members that must be addressed for successful adaption to prolonged space missions.
"The success of human interplanetary spaceflight, which is anticipated to be in this century, will depend on the ability of astronauts to remain confined and isolated from Earth much longer than previous missions or simulations," said David F. Dinges, PhD, professor and chief, Division of Sleep and Chronobiology in the Department of Psychiatry at the Perelman School of Medicine, and co-lead author of the new study. "This is the first investigation to pinpoint the crucial role that sleep-wake cycles will play in extended space missions."
The 520-day simulation, which was developed by the Institute for Biomedical Problems (IBMP) of the Russian Academy of Sciences, and sponsored in part by the European Space Agency (ESA), was initiated on June 3, 2010 when the hatches were closed on a 550-cubic-meter IBMP spacecraft-like confinement facility in Russia. The simulated mission, involving an international, six-man team of volunteers, involved more than 90 experiments and realistic scenarios to gather valuable psychological and medical data on the effects of a long-term deep space flight. The 520-day mission was broken into three phases: 250 days for the trip to Mars, 30 days on the surface, and 240 days for the return to Earth.
“As the only U.S. research team involved with the Mars 520-day simulation, the study required international coordination and strong collaborations to ensure that the experiments were conducted in a thorough and rigorous manner,” said Jeffrey P. Sutton, MD, PhD, professor and director, Center for Space Medicine at Baylor College of Medicine, and senior study author. The investigators monitored the crew's rest-activity patterns, performance and psychological responses to determine the extent to which sleep loss, fatigue, stress, mood changes and conflicts occurred during the mission.
Measurements included continuous recordings of body movements using wrist actigraphy (a noninvasive means of estimating sleep and movement intensity), and light exposure and weekly computer-based neurobehavioral assessments to identify changes in the crew's activity levels, sleep quantity and quality, sleep–wake intervals, alertness performance, and workload throughout the 17 months of mission confinement.
Data from the actigraph devices revealed that crew sedentariness increased across the mission, as illustrated by decreased waking movement and increased sleep and rest times. The majority of crewmembers also experienced one or more disturbances of sleep quality, alertness deficits, or altered sleep–wake intervals and timing, suggesting inadequate circadian synchronization.
"Taken together, these measurements point to the need to identify markers of differential vulnerability to abnormal decrease in muscular movement and sleep– wake changes in crew members during the prolonged isolation of exploration spaceflight and the need to ensure maintenance of the Earth's natural circadian rhythm, sleep quantity and quality, and optimal activity levels during exploration missions," said Mathias Basner, MD, PhD, MSc, assistant professor of Sleep and Chronobiology in Psychiatry at Penn, and co-lead author.
The research team concludes that successful adaptation to such missions will require crews to transit in spacecraft and live in surface habitats that artificially mimic aspects of Earth's sleep-wake activity cycles, such as appropriately timed light exposure, food intake, and exercise. This dynamic will be necessary to maintain neurocognition and human behavior throughout the flight.
The findings also have implications for the increasing prevalence of sleep and circadian rhythm disorders in mainstream society. The research team notes that many people in industrialized societies exist with sedentary lifestyles, prolonged artificial light exposure, and disruptions in healthy sleep patterns due to education and work schedules, leading to other comorbid health conditions such as obesity.
"A takeaway message from this line of research is the life-sustaining importance that healthy sleep duration and timing plays for everyone," Dinges said. "As a global society, we need to reevaluate how we view sleep as it relates to our overall health and ability to lead productive lives. Whether it is an astronaut being challenged to reach another planet or a newborn baby just learning to walk, the human body's need for sleep is as essential as our need for food and water and integral to our ability to thrive."
Other study authors from Penn include Adrian Ecker, Christopher W. Jones, Eric C. Hyder, Adrian Di Antonio, and Namni Goel.
The research was supported by grants from the National Space Biomedical Research Institute through National Aeronautics and Space Administration cooperative agreement (NCC 9-58) and by the Institute for Experimental Psychiatry Research Foundation.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.